Multicenter Symphony™ IL-6 Monitoring Sepsis ED Pilot Study
Key facts
- Who runs it
- Bluejay Diagnostics, Inc.
- Where
- Boston, Gainesville, Nashville, Salt Lake City, and Winston-Salem, United StatesSee the 5 sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 450 people, planned
- Started
- 4 May 2026
- Expected to end
- 30 Dec 2026
- Type of study
- Observational, 3 groups
- Record updated
- 29 September 2026
Who can take part
- Age
- 22 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 25 criteriaShow less
Who can take part
- Adult patients (≥22 years of age)
- Intent to admit to hospital or admitted to the hospital via the emergency department
- At least 0.6 mL plasma drawn (optimal 1 mL) and available for collection (or is anticipated to be able to be drawn and available) within 12 hours of (i.e., up to 12 hours after) presentation to the emergency department. For Cohort 1, Criterion #1 criteria should be met within 3 hours of sample collection (fresh or remnant)
- Meets criteria for at least one of the 3 cohorts (patients may be included in more than one cohort) within 12 hours of emergency department presentation:; Cohort 1 (Systemic inflammatory response or culture ordered):
- Criterion #1 (2 of below within 3 hours of sample collection, of which 1 is at least (A) or (B))
- A) body temperature >38C or <36C,
- B) HR>90 beats/min,
- C) respiratory rate >20 breaths/min, or
- D) white blood cell count > 12K or <4K/microliters or over 10% immature forms or bands) OR:
- Criterion #2 (order for culture of a body fluid (e.g., blood, urine, sputum)); Cohort 2 (Treatment for suspected infection initiated):
- Meets criteria for Cohort 1 and antimicrobials (antibiotics or antivirals) ordered; Cohort 3 (Confirmed or strong evidence of infection):
- Meets criteria for Cohorts 1 and 2, AND 1 or more of the following criteria:
- Temp >101F (38.3C)
- pneumonia by x-ray or CT,
- Urinalysis with WBC>10/HPF
- Intraabdominal-pelvis infection by CT, U/S, or MRI
- Skin / soft tissue infection by clinical exam
- Evidence of meningitis on LP
- Positive microbiological culture (cultures drawn within 3 days of presentation)
- Suspected line infection (e.g. redness or pus around the line)
Who cannot take part
- Prior enrollment into this study
- Prisoners or imprisonment at time of enrollment
- Pregnant
- Informed consent as approved by IRB is unable to be obtained
- Environmental exposure (e.g., heat exposure)
Where in United States
- Beth Israel Deaconess Medical CenterBoston, United States
- University of Florida College of MedicineGainesville, United States
- Vanderbilt University Medical CenterNashville, United States
- Intermountain HealthSalt Lake City, United States
- Wake Forest School of MedicineWinston-Salem, United States
About the trial
What the trial wants to find out
The primary objective of this study is to establish an IL-6 concentration cutoff that predicts sepsis or septic shock (according to the Third International Consensus Definitions (Sepsis-3 criteria)) in patients who are admitted or are intended to be admitted to the hospital from the emergency department with suspected infection.
The 3 groups in the trial
- Cohort 1: Systemic inflammatory response or culture ordered
Criterion #1: (2 of the following within 3 hours of sample collection, of which 1 is at least (A or B): A) body temp \>38c or \<36c B) HR \>90bpm C) respiratory rate \>20 breaths/min D) white blood cell count \>12k or \<4k/microliters or over 10% immature forms or bands, OR Criterion #2: order for culture of a body fluid (blood, urine, sputum)
- Cohort 2: Treatment for suspected infection initiated
Meets criteria for Cohort 1 and antimicrobials (antibiotics or antivirals) ordered
- Cohort 3: Confirmed or strong evidence of infection
Meets criteria for Cohorts 1 and 2, AND 1 or more of the following criteria: Temp \>101F (38.3c) Pneumonia by X-ray or CT Urinalysis with WBC \>10/HPF Intraabdominal-pelvis infection by CT U/S or MRI Skin/soft tissue infection by clinical exam Evidence of meningitis on LP Positive microbiological culture (cultures drawn within 3 days of presentation) Suspected line infection (e.g., redness or pus around the line)
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 29 September 2026